PMV Pharmaceuticals, Inc.
(NASDAQ : PMVP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. 2.58%232.267.5%$414.79m
PAGSPagSeguro Digital Ltd. 3.99%39.230.0%$186.57m
BTBTBit Digital, Inc. 5.55%11.980.0%$183.66m
CRLCharles River Laboratories International, Inc. 2.14%421.344.5%$153.35m
EFXEquifax, Inc. -1.85%268.122.0%$151.38m
CPRTCopart, Inc. 0.75%149.244.4%$119.63m
FLTFLEETCOR Technologies, Inc. -0.10%275.133.6%$117.03m
CHGGChegg, Inc. -1.91%61.6013.1%$107.14m
FOURShift4 Payments, Inc. 0.73%76.990.0%$83.33m
MRVIMaravai Lifesciences Holdings, Inc. 2.27%40.790.0%$73.42m
TASKTaskUs, Inc. -5.27%63.950.0%$70.11m
BAHBooz Allen Hamilton Holding Corp. 0.04%81.002.1%$69.21m
PPDPPD, Inc. -0.18%46.950.0%$67.87m
CLVTClarivate Plc 1.78%22.260.0%$66.39m
TALTAL Education Group 0.62%4.880.7%$61.45m

Company Profile

PMV Pharmaceuticals, Inc. engages in the development of p53 targeted small molecule drugs for the treatment of cancer. It combines unique biological understanding with pharmaceutical development focus. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in 2013 and is headquartered in Cranbury, NY.